Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R et al
Dual agonists such as tirzepatide and emerging triple agonists, including retatrutide, have shown superior weight-loss efficacy in adult populations
Visit our website: To nominate for Top Healthcare Technology CEOs of 2025, click here: Sign up for our free email newsletter at #HealthcareTechnology #DrugDelivery #GLP1 #ObesityCare #MedicalDevices #BiotechInnovation The insights shared here are incredibly valuable
Clinical data shows that after use, skin brightness increases by an average of 22.8%, and melanin density decreases by 31.4%
This can be problematic for people with certain health conditions or older adults whose digestive efficiency may be compromised
As a consultant obstetrician-gynaecologist, I look after women across the life course